DRRX
DURECT Corporation (DRRX)
$81
About DURECT Corporation (DRRX)
DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic regulator. The company was founded by James E. Brown and Felix Theeuwes on February 6, 1998 and is headquartered in Cupertino, CA.
Details
Daily high
$0.82
Daily low
$0.79
Price at open
$0.81
52 Week High
$1.88
52 Week Low
$0.70
Market cap
25.1M
Dividend yield
0.00%
Volume
32,904
Avg. volume
36,224
P/E ratio
-1.22
DURECT Corporation News
Details
Daily high
$0.82
Daily low
$0.79
Price at open
$0.81
52 Week High
$1.88
52 Week Low
$0.70
Market cap
25.1M
Dividend yield
0.00%
Volume
32,904
Avg. volume
36,224
P/E ratio
-1.22